Ex­clu­sive: SEC ex­pect­ed to drop in­ves­ti­ga­tion of Il­lu­mi­na's $8B Grail deal

The SEC is ex­pect­ed to drop an in­ves­ti­ga­tion in­to Il­lu­mi­na’s $8 bil­lion ac­qui­si­tion of can­cer test de­vel­op­er Grail, End­points News has learned.

In 2023, Il­lu­mi­na …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER